042. Denosumab-associated osteonecrosis of the jaw in NSCLC patient: a case report

BACKGROUND: Osteonecrosis of the jaw (ONJ) following bisphosphonate use is well documented. However, to our knowledge, there are few cases reported on ONJ related to the use of other pharmaceutical agents, such as denosumab—a receptor activator of nuclear factor kappa-B ligand (RANKL) inhibitor that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Boutsikou, Efimia, Dalampiras, Stergios, Zarogoulidis, Paul, Spyratos, Dionysios, Porpodis, Konstantinos, Eleptheriadou, Ellada, Zarogoulidis, Konstantinos
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2015
Assuntos:
The Pan Hellenic Congress Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4332111/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados